BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2022

Mar 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2022-03-10

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-10	Common Stock	M	15000	$37.46	Acquired	353569	Direct
2022-03-10	Common Stock	S	15000	$77.57	Disposed	338569	Direct
2022-03-11	Common Stock	M	15000	$37.46	Acquired	353569	Direct
2022-03-11	Common Stock	S	15000	$77.81	Disposed	338569	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-10	Stock Option (Right to buy Common Stock)	$37.46	M	15000	Disposed	2022-05-07	Common Stock (15000)	Direct
2022-03-11	Stock Option (Right to buy Common Stock)	$37.46	M	15000	Disposed	2022-05-07	Common Stock (15000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247533	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on December 9, 2021.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.